Thirdly, STS, the enzyme responsible for the hydrolysis of steroid sulphates to their unconjugated biologically active forms, is overexpressed in breast cancer and is known to be associated with a worse outcome [4, 5]. This evidence concerns the gene STS and breast carcinoma.